New DOJ Opioid Cases Highlight Importance Of Red Flags

By Michael Blume and Todd Halpern ( March 4, 2019, 2:08 PM EST) -- The U.S. Department of Justice is at it again. Writing for Law360 last September, we highlighted United States v. Tricaso and United States v. Gerber, two cases in which the DOJ took an unusual step in addressing the illegitimate sale of controlled substances. In those cases, the DOJ was, in our words, "[d]usting off … obscure, seldom-considered statutory provisions" to prohibit two doctors from selling controlled substances without any legitimate medical purpose....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!